103 related articles for article (PubMed ID: 29496429)
1. Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.
Rota RP; Palacios CA; Temprana CF; Argüelles MH; Mandile MG; Mattion N; Laimbacher AS; Fraefel C; Castello AA; Glikmann G
J Virol Methods; 2018 Jun; 256():24-31. PubMed ID: 29496429
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.
Laimbacher AS; Esteban LE; Castello AA; Abdusetir Cerfoglio JC; Argüelles MH; Glikmann G; D'Antuono A; Mattion N; Berois M; Arbiza J; Hilbe M; Schraner EM; Seyffert M; Dresch C; Epstein AL; Ackermann M; Fraefel C
Mol Ther; 2012 Sep; 20(9):1810-20. PubMed ID: 22713696
[TBL] [Abstract][Full Text] [Related]
3. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine.
El-Senousy WM; Shahein YE; Barakat AB; Ghanem HE; El-Hakim AE; Ameen SM
Int J Biol Macromol; 2013 Aug; 59():67-71. PubMed ID: 23588003
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
6. [Immunoreactivity of chimeric proteins carrying poliovirus epitopes on the VP6 of rotavirus as a vector].
Pan XX; Zhao BX; Teng YM; Xia WY; Wang J; Li XF; Liao GY; Yang С; Chen YD
Mol Biol (Mosk); 2016; 50(5):828-837. PubMed ID: 27830685
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
[TBL] [Abstract][Full Text] [Related]
8. [The genetic stability of recombinant adenovirus expressing human rotavirus VP6 gene which used Ad41 as vector].
Wang M; Chen DL; Song JD; Qu JG; Lu ZZ; Zhao WM; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):422-4. PubMed ID: 23627019
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
Malm M; Heinimäki S; Vesikari T; Blazevic V
Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
[TBL] [Abstract][Full Text] [Related]
10. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
11. [Expression of the main structural antigen VP6 of human rotavirus by recombinant adenovirus and immune responses induced in vivo].
He J; Wang J; Jiang X; Wang D; Wen L; Dong J; Qu J; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):109-13. PubMed ID: 12196818
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs.
Zhao B; Pan X; Teng Y; Xia W; Wang J; Wen Y; Chen Y
Virol Sin; 2015 Oct; 30(5):363-70. PubMed ID: 26459269
[TBL] [Abstract][Full Text] [Related]
13. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
[TBL] [Abstract][Full Text] [Related]
14. HSV-1 amplicon vectors as genetic vaccines.
Laimbacher AS; Fraefel C
Methods Mol Biol; 2014; 1144():99-115. PubMed ID: 24671679
[TBL] [Abstract][Full Text] [Related]
15. Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species.
Eren E; Zamuda K; Patton JT
Virology; 2016 Jan; 487():150-62. PubMed ID: 26524514
[TBL] [Abstract][Full Text] [Related]
16. A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins.
Teng Y; Zhao B; Pan X; Wen Y; Chen Y
Viral Immunol; 2014 Apr; 27(3):96-104. PubMed ID: 24702286
[TBL] [Abstract][Full Text] [Related]
17. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.
D'Antuono A; Laimbacher AS; La Torre J; Tribulatti V; Romanutti C; Zamorano P; Quattrocchi V; Schraner EM; Ackermann M; Fraefel C; Mattion N
Vaccine; 2010 Oct; 28(46):7363-72. PubMed ID: 20851082
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic characterization of VP6 gene (inner capsid) of porcine rotavirus C collected in Japan.
Suzuki T; Hasebe A; Miyazaki A; Tsunemitsu H
Infect Genet Evol; 2014 Aug; 26():223-7. PubMed ID: 24929122
[TBL] [Abstract][Full Text] [Related]
19. Evidence for zoonotic transmission of group C rotaviruses among children in Belém, Brazil.
Gabbay YB; Borges AA; Oliveira DS; Linhares AC; Mascarenhas JD; Barardi CR; Simões CM; Wang Y; Glass RI; Jiang B
J Med Virol; 2008 Sep; 80(9):1666-74. PubMed ID: 18649333
[TBL] [Abstract][Full Text] [Related]
20. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
